Mirum Pharmaceuticals Inc (MIRM) — Capital Reinvestment Ratio
Mirum Pharmaceuticals Inc (MIRM) has a Capital Reinvestment Ratio of 0.10x as of December 2025, meaning it reinvests 0% of its operating cash flow ($6.07 Million) in capital expenditures ($600.00K). Check tangible net worth ratio of Mirum Pharmaceuticals Inc to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Mirum Pharmaceuticals Inc Capital Reinvestment Ratio (2024–2025)
This chart tracks Mirum Pharmaceuticals Inc's Capital Reinvestment Ratio across 2 annual periods. For the full cash flow conversion analysis, see Mirum Pharmaceuticals Inc operating cash flow efficiency.
Annual Capital Reinvestment Ratio for Mirum Pharmaceuticals Inc (2024–2025)
Year-by-year Capital Reinvestment Ratio for Mirum Pharmaceuticals Inc from 2024 to 2025. See Mirum Pharmaceuticals Inc free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.02x | $55.83 Million | $954.00K | ▼ -82.2% |
| 2024 | 0.10x | $10.32 Million | $993.00K | — |